L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) a pris une d\u00e9cision de suspension et de retrait du produit \u00ab FastPen 40mg \u00bb, pr\u00e9sent\u00e9 comme contenant un agoniste du GLP-1, le retatrutide. La d\u00e9cision, prise par le directeur g\u00e9n\u00e9ral adjoint charg\u00e9 des op\u00e9rations, s\u2019appuie sur plusieurs dispositions du code de la sant\u00e9 publique relatives aux m\u00e9dicaments, \u00e0 la publicit\u00e9 et aux pouvoirs de police sanitaire (notamment les articles L.4211-1, L.5111-1, L.5121-8, L.5122-1 \u00e0 L.5122-3, L.5122-6, L.5124-1, L.5311-1, L.5312-2 et L.5312-3).<\/p>\n
L\u2019ANSM avait, par courrier \u00e9lectronique du 3 ao\u00fbt 2026, sollicit\u00e9 les observations de la soci\u00e9t\u00e9 AZRL LTD sur un projet de d\u00e9cision visant \u00e0 suspendre les op\u00e9rations portant sur \u00ab FastPen 40mg \u00bb jusqu\u2019\u00e0 mise en conformit\u00e9 avec la r\u00e9glementation applicable ; ce courrier est rest\u00e9 sans r\u00e9ponse. Le produit est promu et vendu en ligne par la soci\u00e9t\u00e9 AZRL LTD via le site www.azentralabs.com \u00e0 destination de consommateurs fran\u00e7ais, sous forme injectable, voie d\u2019administration consid\u00e9r\u00e9e comme \u00e0 haut risque, et avec la mention \u00ab \u00c0 usage exclusif dans un environnement de laboratoire \u00bb. Il est pr\u00e9sent\u00e9 comme contenant du retatrutide, appartenant \u00e0 la classe des agonistes du GLP-1, classe d\u00e9j\u00e0 utilis\u00e9e en France dans des sp\u00e9cialit\u00e9s pharmaceutiques autoris\u00e9es pour le traitement du diab\u00e8te de type 2 insuffisamment contr\u00f4l\u00e9 ou pour le contr\u00f4le du poids en cas d\u2019ob\u00e9sit\u00e9 ou de surpoids avec complications.<\/p>\n
Le produit est assorti d\u2019all\u00e9gations de type \u00ab stylo injecteur pr\u00e9rempli de peptide amaigrissant \u00bb et valorise les effets des traitements GLP-1 sur la diminution de l\u2019app\u00e9tit et des fringales, ce qui rapproche sa pr\u00e9sentation de celle d\u2019un m\u00e9dicament amaigrissant. Dans ce contexte, l\u2019ANSM d\u00e9cide de suspendre la mise sur le march\u00e9, \u00e0 titre gratuit ou on\u00e9reux, la distribution, la d\u00e9tention en vue de la vente ou de la distribution gratuite, l\u2019importation, l\u2019exportation, l\u2019exploitation et la publicit\u00e9 de \u00ab FastPen 40mg \u00bb, et d\u2019ordonner le retrait du produit en tout lieu o\u00f9 il se trouve. Cette d\u00e9cision illustre l\u2019exercice des pouvoirs de police sanitaire de l\u2019ANSM pour encadrer les produits revendiquant des effets m\u00e9dicamenteux, en particulier lorsqu\u2019ils concernent des agonistes du GLP-1 et qu\u2019ils sont commercialis\u00e9s en ligne aupr\u00e8s du public fran\u00e7ais en dehors du cadre r\u00e9glementaire applicable aux m\u00e9dicaments.\u00a0(contenu r\u00e9sum\u00e9 par l’IA)Lire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":" L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) a pris une d\u00e9cision de suspension et de retrait du produit \u00ab FastPen 40mg \u00bb, pr\u00e9sent\u00e9 comme contenant […]<\/p>\n","protected":false},"author":1,"featured_media":3852,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[63,227],"class_list":["post-16324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-ansm","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/16324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16324"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/16324\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/3852"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}